Skip to main content
GutCited

페퍼민트 오일 그림

13 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1

The Canadian Association of Gastroenterology clinical practice guideline provides an evidence-based framework for managing irritable bowel syndrome, covering diagnosis, dietary modifications, pharmacological treatments, and psychological interventions.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 2
Figure 2 Flowchart

Diagnostic criteria for IBS rely on symptom-based assessment using Rome IV criteria, with limited use of diagnostic tests. Serological screening for celiac disease is recommended as part of the initial evaluation.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

The consensus group concluded that while studies suggest benefits with probiotic therapies overall, and with combination
Figure 3

Evidence evaluation for probiotic therapies in IBS suggests overall benefit, particularly with combination probiotic preparations. Strain-specific recommendations remain difficult due to heterogeneity in study designs and products evaluated.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 4
Figure 4

Dietary interventions for IBS include the low-FODMAP diet, which has demonstrated efficacy in reducing bloating, abdominal pain, and altered bowel habits. A dietitian-guided three-phase approach (restriction, reintroduction, personalization) is recommended.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Key evidence: Two RCTs that fulfilled inclusion criteria for this consensus, compared polyethylene glycol 3350 (PEG) and placebo in a total of 181 patients with Rome (II or III) diagnosed IBS-C (165, 166). Compared with placebo, there was a statistically
Figure 5 Chart

Polyethylene glycol 3350 is evaluated for IBS with constipation based on two RCTs totaling 181 patients. Evidence supports its use for improving stool consistency, though effects on abdominal pain are less consistent.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 6
Figure 6

Antispasmodic agents including peppermint oil, pinaverium, and trimebutine receive conditional recommendations for IBS symptom management. Evidence quality varies across specific agents.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

IBS is diagnosed based on symptoms, with limited use of diagnostic tests; however, serological testing is suggested to exclude celiac disease.
Figure 7 Flowchart

An algorithmic approach to IBS management stratifies treatment by predominant bowel habit (IBS-C, IBS-D, IBS-M) and symptom severity. First-line interventions include dietary modification and fiber supplementation.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 8
Figure 8

Summary recommendations across all therapeutic categories for IBS are presented with corresponding evidence quality ratings and strength of recommendation. The guideline emphasizes shared decision-making with patients.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 5
Figure 5 Forest Plot

Subgroup analyses by peppermint oil formulation (enteric-coated versus non-enteric-coated) reveal that enteric coating may enhance efficacy by delivering the active compound directly to the lower gastrointestinal tract.

The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis …

Figure 9
Figure 9 Chart

Sensitivity analyses excluding high-risk-of-bias studies confirm the robustness of the treatment effect. The benefit of peppermint oil persists regardless of IBS subtype or study quality.

The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis …

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions
Figure 1

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 2
Figure 2

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 1. Main mechanisms of action of functional foods, herbal medicine, and other nutraceuticals in IBS. Each icon next to the medicinal products indicates which of the five main pathophysiological mechanisms of IBS the product targets.
Figure 1

Figure 1. Main mechanisms of action of functional foods, herbal medicine, and other nutraceuticals in IBS. Each icon next to the medicinal products indicates which of the five main pathophysiological …

Functional Foods and Nutraceuticals in Irritable Bowel Syndrome.